FDA.reportPublic FDA data

budesonide 9 MG 24 HR Extended Release Oral Tablet

RxCUI
1366550
RxNorm name
budesonide 9 MG 24 HR Extended Release Oral Tablet
Display name
budesonide 9 MG 24 HR Extended Release Oral Tablet
Full name
budesonide 9 MG 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BudesonideBUDESONIDEMylan Pharmaceuticals Inc.f7265276-e649-4bc4-8ac8-1f5ac2b984e82024-11-15Warnings, Adverse reactionsExact identifier
rxcui: 1366550
budesonideBUDESONIDEOceanside Pharmaceuticalsa12b2e99-c8b3-4d08-9af0-8c4a4376ebf12024-10-25Warnings, Adverse reactionsExact identifier
rxcui: 1366550
UcerisBUDESONIDESantarus Inc.92cbb190-8851-46ed-bfe0-166ca62ef2e92024-10-21Warnings, Adverse reactionsExact identifier
rxcui: 1366550
BudesonideBUDESONIDEActavis Pharma, Inc.41d4fd39-81ee-41be-b34d-efb12b3a359d2024-06-20Warnings, Adverse reactionsExact identifier
rxcui: 1366550

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
41d4fd39-81ee-41be-b34d-efb12b3a359dbudesonide 9 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR budesonide 9 MG Extended Release Oral Tablet [SCD] · budesonide 9 MG 24 HR Extended Release Oral Tablet [SY]321These highlights do not include all the information needed to use BUDESONIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for BUDESONIDE EXTENDED-RELEASE TABLETS. BUDESONIDE extended-release tablets, for oral use Initial U.S. Approval: 199720240620
92cbb190-8851-46ed-bfe0-166ca62ef2e9budesonide 9 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR budesonide 9 MG Extended Release Oral Tablet [SCD] · budesonide 9 MG 24 HR Extended Release Oral Tablet [SY]320These highlights do not include all the information needed to use UCERIS safely and effectively. See full prescribing information for UCERIS. UCERIS ® (budesonide) extended-release tablets, for oral use Initial U.S. Approval: 199720241021
f7265276-e649-4bc4-8ac8-1f5ac2b984e8budesonide 9 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR budesonide 9 MG Extended Release Oral Tablet [SCD] · budesonide 9 MG 24 HR Extended Release Oral Tablet [SY]38These highlights do not include all the information needed to use BUDESONIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for BUDESONIDE EXTENDED-RELEASE TABLETS . BUDESONIDE extended-release tablets, for oral use Initial U.S. Approval: 199720241115
a12b2e99-c8b3-4d08-9af0-8c4a4376ebf1budesonide 9 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR budesonide 9 MG Extended Release Oral Tablet [SCD] · budesonide 9 MG 24 HR Extended Release Oral Tablet [SY]38These highlights do not include all the information needed to use BUDESONIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for BUDESONIDE EXTENDED-RELEASE TABLETS. BUDESONIDE extended-release tablets, for oral use Initial U.S. Approval: 199720241025